Intramyocellular lipid quantification: comparison between 3.0- and 1.5-T 1H-MRS

Magnetic Resonance Imaging

Volumn 25, Issue 7, 2007, Pages 1105-1111

  Torriani, Martin ^a   Thomas, Bijoy J ^a   Bredella, Miriam A ^a   Ouellette, Hugue ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

3.0 T; Lipids; Muscle; Proton magnetic resonance spectroscopy

Indexed keywords

LIPID;

ACCURACY; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FOLLOW UP; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; WILCOXON SIGNED RANKS TEST;

ADULT; BODY MASS INDEX; HUMANS; LEG; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 34547729082     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2006.12.003     Document Type: Article

References (25)

1. Schick F., Eismann B., Jung W.I., Bongers H., Bunse M., and Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 29 (1993) 158-167
2. Boesch C., Slotboom J., Hoppeler H., and Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37 (1997) 484-493
3. Jacob S., Machann J., Rett K., et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48 (1999) 1113-1119
4. Krssak M., Falk Petersen K., Dresner A., et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42 (1999) 113-116
5. Levin K., Daa Schroeder H., Alford F.P., and Beck-Nielsen H. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 44 (2001) 824-833
6. Sinha R., Dufour S., Petersen K.F., et al. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51 (2002) 1022-1027
7. Torriani M., Thomas B.J., Barlow R.B., Librizzi J., Dolan S., and Grinspoon S. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution. J Appl Physiol 100 (2006) 609-614
8. Szczepaniak L.S., Babcock E.E., Schick F., et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276 (1999) E977-E989
9. Torriani M., Thomas B.J., Halpern E.F., Jensen M.E., Rosenthal D.I., and Palmer W.E. Intramyocellular lipid quantification: repeatability with 1H MR spectroscopy. Radiology 236 (2005) 609-614
10. Kantarci K., Reynolds G., Petersen R.C., et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. AJNR Am J Neuroradiol 24 (2003) 843-849
11. Barker P.B., Hearshen D.O., and Boska M.D. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 45 (2001) 765-769
12. Duewell S.H., Ceckler T.L., Ong K., et al. Musculoskeletal MR imaging at 4 T and at 1.5 T: comparison of relaxation times and image contrast. Radiology 196 (1995) 551-555
13. Gold G.E., Han E., Stainsby J., Wright G., Brittain J., and Beaulieu C. Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. AJR Am J Roentgenol 183 (2004) 343-351
14. Behrens G.M., Boerner A.R., Weber K., et al. Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy. J Clin Invest 110 (2002) 1319-1327
15. Skoch A., Jiru F., Dezortova M., et al. Intramyocellular lipid quantification from 1H long echo time spectra at 1.5 and 3 T by means of the LCModel technique. J Magn Reson Imaging 23 (2006) 728-735
16. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30 (1993) 672-679
17. Naressi A., Couturier C., Devos J.M., et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 12 (2001) 141-152
18. Kuczmarski R.J., and Flegal K.M. Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 72 (2000) 1074-1081
19. Frayne R., Goodyear B.G., Dickhoff P., Lauzon M.L., and Sevick R.J. Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38 (2003) 385-402
20. Gonen O., Gruber S., Li B.S., Mlynarik V., and Moser E. Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol 22 (2001) 1727-1731
21. Bartha R., Drost D.J., Menon R.S., and Williamson P.C. Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla. Magn Reson Med 44 (2000) 185-192
22. Boesch C., Decombaz J., Slotboom J., and Kreis R. Observation of intramyocellular lipids by means of 1H magnetic resonance spectroscopy. Proc Nutr Soc 58 (1999) 841-850
23. Decombaz J., Schmitt B., Ith M., et al. Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. Am J Physiol Regul Integr Comp Physiol 281 (2001) R760-R769
24. Jansen J.F., Backes W.H., Nicolay K., and Kooi M.E. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 240 (2006) 318-332
25. Larson-Meyer D.E., Smith S.R., Heilbronn L.K., Kelley D.E., Ravussin E., and Newcomer B.R. Muscle-associated triglyceride measured by computed tomography and magnetic resonance spectroscopy. Obesity (Silver Spring) 14 (2006) 73-87